N
NGM Biopharmaceuticals Inc
F:0IK
NGM Biopharmaceuticals Inc
F:0IK
Price:
3.03
EUR
-0.66%
Market Closed
Market Cap:
€252.9m
Cash Flow Statement
Cash Flow Statement
NGM Biopharmaceuticals Inc
NGM Biopharmaceuticals Inc
Currency: USD
| Dec-2024 | Jun-2025 | ||
|---|---|---|---|
| Operating Cash Flow | |||
| Net Income |
18
|
14
|
|
| Depreciation & Amortization |
11
|
12
|
|
| Stock-Based Compensation |
5
|
7
|
|
| Other Non-Cash Items |
6
|
9
|
|
| Cash Taxes Paid |
4
|
0
|
|
| Cash Interest Paid |
0
|
1
|
|
| Change in Working Capital |
(37)
|
(16)
|
|
| Cash from Operating Activities |
(3)
N/A
|
19
N/A
|
|
| Investing Cash Flow | |||
| Capital Expenditures |
(23)
|
(21)
|
|
| Cash from Investing Activities |
(23)
N/A
|
(22)
+6%
|
|
| Financing Cash Flow | |||
| Net Issuance of Common Stock |
41
|
0
|
|
| Net Issuance of Debt |
(2)
|
(2)
|
|
| Other |
(9)
|
(1)
|
|
| Cash from Financing Activities |
30
N/A
|
(4)
N/A
|
|
| Change in Cash | |||
| Effect of Foreign Exchange Rates |
0
|
1
|
|
| Net Change in Cash |
4
N/A
|
(6)
N/A
|
|
| Free Cash Flow | |||
| Free Cash Flow |
(26)
N/A
|
(3)
+89%
|
|
Switch to:
Switch to:
See Also
Discover More
